Month: February 2010

New Cycle Begins for Lab and Pathology Acquisitions

THERE’S A NEW TRANSITION JUST GETTING STARTED in the laboratory testing industry. For the past two decades, laboratory acquisition activity has primarly centered around independent clinical laboratories—often owned by local pathologists. This was true in both the size of the transactions and in the volume of transactions. Our stories on pages 3-9 describe these processes. …

New Cycle Begins for Lab and Pathology Acquisitions Read More »

Pace of Lab Acquisitions Increased during 2009

CEO SUMMARY: After two years of relatively slow sales of clinical labs, there is pent up demand for lab acquisitions and a declining supply of independent labs available for sale. That’s the assessment of one expert on laboratory mergers and acquisitions, who predicts that the accelerating pace of clinical lab and anatomic pathology practice acquisitions …

Pace of Lab Acquisitions Increased during 2009 Read More »

Predict 2010 To Be Busy For Lab Owners & Buyers

CEO SUMMARY: Along with a recovering economy, the possibility of an increase in the capital gains tax rate for 2011 may encourage owners of clinical labs and anatomic pathology companies to sell their businesses during 2010. That could make 2010 a busy year for laboratory mergers and acquisitions, particularly if valuations for laboratory companies hold …

Predict 2010 To Be Busy For Lab Owners & Buyers Read More »

Multispectral Tests Use “Smart” Systems To Analyze Tissue

CEO Summary: Pathologists at the Hospital of the University of Pennsylvania are using a new system that combines image analysis software and algorithms to evaluate images containing numerous stains and biomarkers. Pathologists teach the system to identify tumor cells and distinguish them from non-tumor cells. Now used for research purposes, this sophisticated digital pathology system …

Multispectral Tests Use “Smart” Systems To Analyze Tissue Read More »

Beckman Coulter, Olympus, LabCorp, Anthem, WellPoint, Medtox, University of Toronto

BECKMAN COULTER REPORTS EARNINGS THAT INCLUDE OLYMPUS THERE WAS A BIG JUMP in fourth quarter revenue at Beckman Coulter Inc., of Brea, California, which increased by 22% over the previous year, to $989.6 million. This number included $120.2 million in revenue from the recent Olympus Diagnostics acquisition. Beckman Coulter spent $800 million in August 2009 …

Beckman Coulter, Olympus, LabCorp, Anthem, WellPoint, Medtox, University of Toronto Read More »

Dark Daily

February 15, 2010 “Intelligence: Late Breaking Lab News”

In response to the sky-rocketing expenses associated with genetic and molecular testing, health insurers are planning ways to control both utilization and the prices at which these tests are reimbursed. For example, during the past year, Humana began using DNA Direct of San Francisco, California, to pre-authorize expensive genetic and molecular tests, while also advising …

February 15, 2010 “Intelligence: Late Breaking Lab News” Read More »